1. Home
  2. Disease & Disorders
  3. Philadelphia, PA
  4. Chrysalis Initiative

Chrysalis Initiative

Chrysalis Initiative has an America's Best Score of 51 out of 100, based on its 2024 Form 990, below the 60-point bar to be ranked.

  • Philadelphia, PA
  • Tax-exempt since 2021
  • EIN: 85-4325601
thechrysalisinitiative.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
51OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Chrysalis Initiative is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G32). Contributions are tax-deductible.

325-41 Chestnut Street Suite 800, Philadelphia, PA 19106-0000

Among the 20 scored disease & disorders organizations in Philadelphia, Chrysalis Initiative holds 1.7 months of operating reserves (peer median 7.6 months), runs a typical yearly surplus of 0.3% (peers: surplus of 6.0%), and has cut spending 11.9% a year (peers: grown spending 11.0% a year).

In fiscal year 2024 it reported $807,238 in revenue and $713,602 in expenses, with contributions making up 84.7% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

The Chrysalis Initiative exists to disrupt outcome disparities within breast cancer, so every patient receives the care they deserve. By providing patients with mentoring and resource navigation and equipping Black women (and other disparate groups) with the opportunity and education to assess their breast cancer risk, we are closing the gap one story at a time.

Largest programs · fiscal year 2024

  • Bc navi app: Provides educational support to patients with breast cancer through training modules, webinars, videos, events, links to helpful websites, and more. $256,216 spent · 49.1% of program spending
  • Coaching: One-on-one coaching exists to edify and empower patients through their treatment, helping them to feel confident and in charge by managing the worries and challenges particular to their journey. $233,616 spent · 44.8% of program spending
  • Equity assessment cohort: The Chrysalis Initiative's equity assessment, tools, and improvement plan, provides an evidence-based system-wide intervention and training for your cancer center or organization and ensures that your cancer care being administered is addressing disparities within the cancer care continuum using a community-based participatory research approach. High-quality breast cancer… Read more

    Equity assessment cohort: The Chrysalis Initiative's equity assessment, tools, and improvement plan, provides an evidence-based system-wide intervention and training for your cancer center or organization and ensures that your cancer care being administered is addressing disparities within the cancer care continuum using a community-based participatory research approach. High-quality breast cancer care across the care continuum includes equity and reduces and, in some cases, eliminates disparities.

    $32,099 spent · 6.2% of program spending

Where each dollar went · fiscal year 2024

Of every dollar it spent, 73¢ went to programs, 23¢ to management and 4¢ to fundraising.

  • Programs $521,931
  • Management $161,483
  • Fundraising $30,188

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score51 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves1.7 mo; 1.7 mo in cash1.2 / 25
Financial balance (median margin)+0.3%15.8 / 20
Transparency3 full 990s, latest TY202420 / 20
Program growth−11.9% / yr1.6 / 15
Track record5 years2 / 10
Debt load0.0% of assets10 / 10
Total50.5 → 51
Spending on programs
Not scored; America's Best needs 65%+
73%Meets

Compared with Philadelphia peers

MeasureThis organizationPeer median
Operating reserves1.7 mo7.6 mo
Typical margin+0.3%+6.0%
Spending growth−11.9% / yr+11.0% / yr
Debt load0.0%17.3%

Peers: the 20 Philadelphia disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$807,238Fiscal year 20242022: $920,75820222023: $1,184,67720232024: $807,2382024
Expenses$713,602Fiscal year 20242022: $918,57920222023: $1,181,20520232024: $713,6022024
Total assets$99,490Fiscal year 20242022: $2,38220222023: $5,85420232024: $99,4902024
Total liabilities$0Fiscal year 20242022: $020222023: $020232024: $02024
Fiscal year ending September 2024
Revenue$807,238
Expenses$713,602
Net income$93,636
Net assets$99,490

Notable sources of revenue

Percent of total revenue
Contributions$683,488
Program services$123,750
Investment income$0
Other (net)$0

Assets / debt

Total assets$99,490
Total liabilities$0
Net assets$99,490

Compensation

Not in our extract for this year.

Fiscal year ending September 2023
Revenue$1,184,677
Expenses$1,181,205
Net income$3,472
Net assets$5,854

Notable sources of revenue

Percent of total revenue
Contributions$1,179,677
Program services$5,000
Investment income$0
Other (net)$0

Assets / debt

Total assets$5,854
Total liabilities$0
Net assets$5,854

Compensation

Not in our extract for this year.

Fiscal year ending September 2022
Revenue$920,758
Expenses$918,579
Net income$2,179
Net assets$2,382

Notable sources of revenue

Percent of total revenue
Contributions$920,758
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets$2,382
Total liabilities$0
Net assets$2,382

Compensation

Officers and key employees$42,326
Share of expenses4.6%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?